Overview
- CEO Chris Kempczinski said the company is experimenting with items tailored to people on drugs like Ozempic and Wegovy, without detailing what might roll out.
- He noted McDonald’s has not seen a material business impact yet but is tracking shifts such as reduced calorie intake, less snacking, and fewer sugary drinks.
- Executive VP Jill McDonald said the chain is already “protein forward” with options like fish, chicken strips, snack wraps, and sausage biscuits, and is exploring longer-term ideas.
- Rivals have introduced GLP-1-friendly offerings, including Smoothie King’s dedicated menu, Olive Garden’s lighter-portion section, Chipotle’s 32-gram protein cup, and Subway’s Protein Pockets.
- A Gallup survey cited by USA TODAY reported GLP-1 use more than doubled from early 2024 to late 2025, reaching 12.4% of respondents.